[1] |
WANG W, JIANG B, SUN H, et al. Prevalence, incidence, and mortality of stroke in China: Results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771. doi:10.1161/circulationaha.116.025250
doi: 10.1161/circulationaha.116.025250
|
[2] |
STAEHR-RYE A K, MEYHOFF C S, SCHEFFENBICHLER F T, et al. High intraoperative inspiratory oxygen fraction and risk of major respiratory complications[J]. Br J Anaesth, 2017, 119(1): 140-149. doi:10.1093/bja/aex128
doi: 10.1093/bja/aex128
|
[3] |
FAN J L, BRASSARD P, RICKARDS C A, et al. Integrative cerebral blood flow regulation in ischemic stroke[J]. J Cereb Blood Flow Metab, 2022, 42(3): 387-403. doi:10.1177/0271678x211032029
doi: 10.1177/0271678x211032029
|
[4] |
HOVAGUIMIAN F, LYSAKOWSKI C, ELIA N, et al. Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary function: Systematic review and meta-analysis of randomized controlled trials[J]. Anesthesiology, 2013, 119(2): 303-316. doi:10.1097/aln.0b013e31829aaff4
doi: 10.1097/aln.0b013e31829aaff4
|
[5] |
周先贵,蒋艳,韩梅,等. miR21-5p靶向转录激活蛋白STAT3减轻高氧性急性肺损伤[J]. 实用医学杂志,2023,39(1):21-27.
|
[6] |
HEGEDUŠ I, MILIĆ J, ĆOSIĆ A, et al. Cerebrovascular reactivity in acute hyperoxia in patients with acute ischaemic stroke[J]. Brain Inj, 2017, 31(4): 560-566. doi:10.1080/02699052.2017.1280853
doi: 10.1080/02699052.2017.1280853
|
[7] |
EJAZ S, EMMRICH J V, SITNIKOV S L, et al. Normobaric hyperoxia markedly reduces brain damage and sensorimotor deficits following brief focal ischaemia[J]. Brain, 2016, 139(Pt 3): 751-764. doi:10.1093/brain/awv391
doi: 10.1093/brain/awv391
|
[8] |
SHIN H K, DUNN A K, JONES P B, et al. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia[J]. Brain, 2007, 130(Pt 6): 1631-1642. doi:10.1093/brain/awm071
doi: 10.1093/brain/awm071
|
[9] |
FOSCHI M, D'ANNA L, DE MATTEIS E, et al. Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort[J]. Stroke, 2025, 56(2): 305-317.
|
[10] |
ZHANG Y, WANG X, GAO Y, et al. Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis[J]. Stroke, 2025, 56(1): 46-55. doi:10.1161/strokeaha.124.049246
doi: 10.1161/strokeaha.124.049246
|
[11] |
KOLBITSCH C, LORENZ I H, HÖRMANN C, et al. The influence of hyperoxia on regional cerebral blood flow (rCBF), regional cerebral blood volume (rCBV) and cerebral blood flow velocity in the middle cerebral artery (CBFVMCA) in human volunteers[J]. Magn Reson Imaging, 2002, 20(7): 535-541. doi:10.1016/s0730-725x(02)00534-9
doi: 10.1016/s0730-725x(02)00534-9
|
[12] |
WATSON N A, BEARDS S C, ALTAF N, et al. The effect of hyperoxia on cerebral blood flow: A study in healthy volunteers using magnetic resonance phase-contrast angiography[J]. Eur J Anaesthesiol, 2000, 17(3): 152-159. doi:10.1046/j.1365-2346.2000.00640.x
doi: 10.1046/j.1365-2346.2000.00640.x
|
[13] |
LI W, LAN J, WEI M, et al. Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): A multicentre, randomised, single-blind, sham-controlled trial[J]. Lancet, 2025, 405(10477): 486-497.
|
[14] |
KURSUN O, KARATAS H, BARISKANER H, et al. Arachidonic acid metabolites in neurologic disorders[J]. CNS Neurol Disord Drug Targets, 2022, 21(2): 150-159. doi:10.2174/1871527320666210512013648
doi: 10.2174/1871527320666210512013648
|
[15] |
CLARKE R J, MAYO G, PRICE P, et al. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin[J]. N Engl J Med, 1991, 325(16): 1137-1141. doi:10.1056/nejm199110173251605
doi: 10.1056/nejm199110173251605
|
[16] |
ROSENBLUM W I. Endothelium-dependent responses in the microcirculation observed in vivo[J]. Acta Physiol (Oxf), 2018, 224(2): e13111. doi:10.1111/apha.13111
doi: 10.1111/apha.13111
|
[17] |
IMIG J D. Eicosanoids and renal vascular function in diseases[J]. Clin Sci (Lond), 2006, 111(1): 21-34. doi:10.1042/cs20050251
doi: 10.1042/cs20050251
|
[18] |
FÉLÉTOU M, HUANG Y, VANHOUTTE P M. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products[J]. Br J Pharmacol, 2011, 164(3): 894-912. doi:10.1111/j.1476-5381.2011.01276.x
doi: 10.1111/j.1476-5381.2011.01276.x
|
[19] |
LIU B, ZHOU Y. Endothelium-dependent contraction: The non-classical action of endothelial prostacyclin, its underlying mechanisms, and implications[J]. FASEB J, 2021, 35(9): e21877. doi:10.1096/fj.202101077r
doi: 10.1096/fj.202101077r
|
[20] |
李松,贺兴友,贺电,等. 老年大动脉粥样硬化型脑梗死患者采用NBP与LIPost C联合治疗的效果分析[J]. 实用医学杂志,2024,40(9):1286-1292.
|
[21] |
KLEEBERG A, LUFT T, GOLKOWSKI D, et al. Endothelial dysfunction in acute ischemic stroke: A review[J]. J Neurol, 2025, 272(2): 143. doi:10.1007/s00415-025-12888-6
doi: 10.1007/s00415-025-12888-6
|
[22] |
HOLSE C, AASVANG E K, VESTER-ANDERSEN M, et al. Hyperoxia and antioxidants for myocardial injury in noncardiac surgery: A 2 × 2 factorial, blinded, randomized clinical trial[J]. Anesthesiology, 2022, 136(3): 408-419. doi:10.1097/aln.0000000000004117
doi: 10.1097/aln.0000000000004117
|
[23] |
FONNES S, GÖGENUR I, SØNDERGAARD E S, et al. Perioperative hyperoxia - long-term impact on cardiovascular complications after abdominal surgery, a post hoc analysis of the PROXI trial[J]. Int J Cardiol, 2016, 215: 238-243. doi:10.1016/j.ijcard.2016.04.104
doi: 10.1016/j.ijcard.2016.04.104
|
[24] |
程卉婷,王彬. 围术期氧疗的研究进展[J]. 临床麻醉学杂志,2024,40(5):549-552.
|